Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD -8.96 M

Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow is USD -8.96 M for the year ending December 31, 2023, a 74.26% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD -34.81 M, a -482.47% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 9.10 M, a -49.13% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 17.89 M, a 118.32% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 8.20 M, a 98.27% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years